CME in Minutes: Education in Cardiology & Pulmonology

Get answers in 25 minutes or less from world-class experts and earn CME/CE credit with CME in Minutes: Education in Cardiology & Pulmonology by Answers in CME. Benefit from digests of latest advancements, thoughtful case studies, and nuanced perspectives. Inspiring and engaging programs designed for busy healthcare professionals to cover the diagnosis, treatment, follow-up, and clinical management of conditions in cardiology, pulmonology. Earning your CME/CE credit has never been faster or easier. Download the URL for each individual program to request continuing education credit or access the slides.

Last refreshed: April 27th, 2026 at 5:44 AM ⓘ

Follow this podcast in the Metacast mobile app to refresh it and see new episodes.

Follow on

Apple Podcasts

Spotify

RSS

Podcasts are better in Metacast mobile app

Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episodes

Advancing Cardio-Kidney-Metabolic Care in Internal Medicine: Evidence-Based Guidance for Incorporating Nonsteroidal MRAs

Please visit answersincme.com/860/101064703-replay to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Muthiah Vaduganathan, MD, MPH and Nosheen Reza, MD, MS. In this activity, experts in cardio-kidney-metabolic syndrome (CKM) discuss emerging evidence on nonsteroidal mineralocorticoid receptor antagonists (nsMRAs) and practical strategies for incorporating these therapies into care for patients with heart failure, with or without...

Apr 17, 2026•1 hr 8 min

Biomarker-Driven Insights in ATTR-CM: Interpreting the Impact of the Latest Evidence

Please visit answersincme.com/BGQ860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Marianna Fontana, MD, PhD. In this activity, an expert in cardiology discusses the role of biomarkers and disease-modifying therapies in transthyretin amyloid cardiomyopathy (ATTR-CM). Upon completion of this activity, participants should be better able to: "Differentiate the mechanisms of action and pharmacologic profiles of approved transthy...

Apr 15, 2026•15 min

Secondary Stroke Prevention Today and Tomorrow: Where Evolving Antithrombotic Strategies May Fit Into Hospitalist Care

Please visit answersincme.com/860/102620367-replay to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Keith C. Ferdinand, MD; and Henry J. Michtalik, MD, MPH, MHS. IIn this activity, experts in preventive cardiology and hospital medicine discuss secondary stroke prevention strategies for hospitalists and internists. Upon completion of this activity, participants should be better able to: Evaluate guideline-recommended secondary s...

Apr 10, 2026•1 hr 1 min

The Next Era of CKD Management in T1D: Evolving Care Strategies to Improve Patient Outcomes

Please visit answersincme.com/FGV860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Janet B. McGill, MD, MA, FACP, MACE. In this activity, an expert in the management of diabetes discusses evolving data on emerging strategies to enhance cardiorenal outcomes in patients with type 1 diabetes (T1D). Upon completion of this activity, participants should be better able to: Review the limitations of current treatment strategies for...

Apr 01, 2026•19 min

From Screening to Specialized Care: Navigating Key Questions in Alpha-1 Antitrypsin Deficiency–Associated Liver Disease

Please visit answersincme.com/KQK860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Virginia Clark, MD, MS. In this activity, an expert in liver disease discusses practical considerations for identifying and managing liver disease related to alpha-1 antitrypsin deficiency (AATD) across the care continuum. Upon completion of this activity, participants should be better able to: Apply strategies to reach a diagnosis of AATD and...

Mar 31, 2026•16 min

Precision Use of Biologic Therapies in Eosinophilic Lung Disease: Case-Based Strategies to Optimize Treatment Selection and Reduce Steroid Burden

Please visit answersincme.com/860/240201375-replay to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by James Michael Ramsahai, BSc, MD, PhD, FRCPC and Nan Zhao, BSc, MD, FRCPC. In this activity, experts in managing severe eosinophilic asthma discuss evidence-based strategies for personalizing biologic therapy, reducing steroid burden, and optimizing treatment in the setting of overlapping eosinophilic diseases. Upon completion of ...

Mar 13, 2026•1 hr 10 min

HoFH in Focus: Practical Strategies for Early Detection and Lifelong Management

Please visit answersincme.com/860/MED-CMB-03166-replay to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Samuel S. Gidding, MD; Pamela B. Morris, MD, FACC and Allison Jamison. In this activity, experts in homozygous familial hypercholesterolemia (HoFH) discuss screening, diagnosis, and treatment strategies to support effective management of this rare inherited lipid disorder. Upon completion of this activity, participants should...

Mar 05, 2026•1 hr 2 min

RAS(ON) Inhibition: On the Path to Overcoming Therapeutic Resistance and Targeting More Variants in KRAS-Mutated NSCLC

Please visit answersincme.com/860/120773-replay to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Alex Spira, MD, PhD, FASCO; and Kathryn C. Arbour, MD. In this activity "In this activity, experts in oncology discuss the evolving role of RAS(ON) inhibitors in shaping future treatment strategies for patients with KRAS-mutated non–small-cell lung cancer (NSCLC). Upon completion of this activity, participants should be better able ...

Mar 02, 2026•1 hr 2 min

Breaking Old Habits in Lung Cancer Detection: Expanding Screening Efforts Among At-Risk Populations

Please visit answersincme.com/RCG860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Raymond Osarogiagbon, MD, MBBS, FACP, FASCO; and Michael Gieske, MD. In this activity, experts in lung cancer discuss practical strategies for lung cancer screening. Upon completion of this activity, participants should be better able to: Recognize barriers to achieving lung cancer screening for eligible patients; Identify patients at high ris...

Feb 10, 2026•18 min

Ticiana Leal, MD - Translating Trials to Treatment: Practical Strategies for Immunotherapy Integration in Limited-Stage and Extensive-Stage SCLC

Please visit answersincme.com/JRV860 to participate, download slides and supporting materials, complete the post test, and get a certificate. In this activity, an expert in lung cancer discusses the use of immunotherapy in clinical practice for patients with limited-stage (LS) and extended-stage (ES) small-cell lung cancer (SCLC). Upon completion of this activity, participants should be better able to: Recognize the rationale for the use of immune checkpoint inhibitors in LS-SCLC and ES-SCLC; As...

Jan 08, 2026•19 min

Taofeek K. Owonikoko, MD, PhD, MS / Ticiana Leal, MD - New Frontiers in Small Cell Lung Cancer: Getting Ready for the Emergence of B7-H3–Directed ADCs

Please visit answersincme.com/860/99097105-replay to participate, download slides and supporting materials, complete the post test, and get a certificate. In this activity, experts in small cell lung cancer (SCLC) discuss the pathophysiologic rationale, emerging clinical evidence, and potential future role for B7-H3–directed antibody-drug conjugates in extensive-stage SCLC. Upon completion of this activity, participants should be better able to: Recognize the rationale for investigating B7-H3–di...

Dec 12, 2025•1 hr 2 min

Nicola Hanania, MD, MS / Surya P. Bhatt, MD, MSPH - Demystifying the Evidence for Biologics in COPD: Strategies for Optimized, Patient-Centered Management

Please visit answersincme.com/860/MED-RESP-03658-replay to participate, download slides and supporting materials, complete the post test, and get a certificate. In this activity, experts in pulmonary medicine discuss how to integrate biologics into individualized treatment plans for chronic obstructive pulmonary disease (COPD), featuring insights from a patient advocate. Upon completion of this activity, participants should be better able to: Specify the rationale for targeting eosinophilic infl...

Dec 11, 2025•1 hr 5 min

Mark Awad, MD, PhD / Carl M. Gay, MD, PhD - Breaking News in Small-Cell Lung Cancer: Expert Insights on B7-H3–Directed Antibody–Drug Conjugates From Recent Congresses

Please visit answersincme.com/860/99224979-replay1 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, experts in oncology discuss the latest data on emerging B7-H3–directed antibody–drug conjugates (ADCs) for the treatment previously treated extensive-stage small-cell lung cancer (ES-SCLC). Upon completion of this activity, participants should be better able to: Specify how B7-H3 overexpression is relevant to ES-SCLC prognosis a...

Dec 01, 2025•1 hr 3 min

Luis Paz-Ares, MD, PhD / Lauren Averett Byers, MD - Shaping the Future of SCLC Treatment: Advancing Care Through Innovative Approaches

Please visit answersincme.com/860/97851223-replay3 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, experts in lung cancer discuss the latest advances in the treatment of small-cell lung cancer (SCLC), including both extensive-stage and limited-stage disease. Upon completion of this activity, participants should be better able to: Identify clinical factors that drive treatment decision-making for patients with SCLC; and Outlin...

Nov 24, 2025•31 min

Anne K. Ellis, MD, MSc, FRCPC / Andrew Thamboo, MD, FRCSC / Meyer Balter, MD, FRCPC - Advancing CRSwNP Care: Multidisciplinary Insights on Early Detection and the Role of Biologic Therapies

Please visit answersincme.com/PME860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, experts in the treatment of chronic rhinosinusitis with nasal polyps (CRSwNP) discuss strategies for optimizing the detection and management of CRSwNP, with a focus on the role of biologics in patient-centered care. Upon completion of this activity, participants should be better able to: Identify best practices to facilitate the early detecti...

Nov 21, 2025•19 min

Luis Paz-Ares, MD, PhD / Kristin Higgins, MD - Creating a Roadmap to Optimize Care for Patients With LS-SCLC: Integrating the Evidence Into Practical Care

Please visit answersincme.com/860/97851223-replay2 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, experts in lung cancer discuss the growing importance of immunotherapy in the management of limited-stage small-cell lung cancer (LS-SCLC). Upon completion of this activity, participants should be better able to: Review the clinical impact of immunotherapy-based regimens for the management of small-cell lung cancer (SCLC); and I...

Oct 30, 2025•31 min

MeiLan Han, MD, MS / Eddie Needham, MD, FAAFP / Valerie Chang - COPD Primary Care Playbook: Boosting Diagnosis, Treatment, and Therapy Escalation for Optimal Disease Control

Please visit answersincme.com/860/MED-RESP-03268-replay to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, a family medicine physician and a pulmonologist discuss strategies for optimizing chronic obstructive pulmonary disease (COPD) detection and management in primary care. Upon completion of this activity, participants should be better able to: Review the latest guideline recommendations on the management of COPD; Identify the...

Oct 17, 2025•1 hr 6 min

Stephanie Christenson, MD, MAS - Beyond Standard Care: Enhancing Disease Control With Biologic Therapy for Eosinophilic COPD

Please visit answersincme.com/XVH860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in pulmonology discusses the role of biologic therapy in patients with eosinophilic chronic obstructive pulmonary disease (COPD). Upon completion of this activity, participants should be better able to: Identify patients with unmet therapeutic needs despite guideline-recommended management of chronic obstructive pulmonary disease (C...

Sep 24, 2025•20 min

Raffaele Califano, MD / Nicolas Girard, MD, PhD / Antonio Passaro, MD, PhD - Reshaping the Management of Metastatic NSCLC: Tackling HER2 Overexpression to Elevate Outcomes

Please visit answersincme.com/860/98320325-replay to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, experts in oncology discuss the evolving role of HER2-targeted antibody–drug conjugates (ADCs) and how to integrate them into clinical practice. Upon completion of this activity, participants should be better able to: Recognize the role of biomarker testing for the management of HER2-overexpressing NSCLC; Evaluate the clinical si...

Sep 10, 2025•55 min

Matthew W. Martinez, MD, FACC, FASE / Brad Mehl, MHA, ACS, RDCS, RVT, RDMS, RT(R), FASE - The Echo Quest: Conquering Real-World Hypertrophic Cardiomyopathy Cases From Diagnosis to Treatment

Please visit answersincme.com/FBG860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, experts in cardiology and cardiac sonography discuss best practices for using echocardiography for the diagnosis and management of obstructive hypertrophic cardiomyopathy, highlighting how echocardiography may guide treatment decisions with cardiac myosin inhibitors. Upon completion of this activity, participants should be better able to: Rev...

Sep 09, 2025•1 hr 19 min

Scott Solomon, MD - Mapping the Future of Heart Failure Care: The Evolving Role of Nonsteroidal MRAs in the Treatment of Patients With Heart Failure and Mildly Reduced/Preserved Ejection Fraction

Please visit answersincme.com/QWE860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in cardiology discusses the evolving role of mineralocorticoid receptor antagonists (MRAs) to treat patients with heart failure. Upon completion of this activity, participants should be better able to: Identify the evolving role of mineralocorticoid receptor antagonists (MRAs) to treat patients with heart failure; Evaluate clinical ...

Sep 01, 2025•18 min

Luis Paz-Ares, MD, PhD / Niels Reinmuth, MD, PhD - Developing a Master Plan for ES-SCLC: A Practical Guide to Elevate Care in the Real-World

Please visit answersincme.com/860/97851223-replay1 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, experts in lung cancer discuss the practical application of immunotherapy-based regimens for the treatment of extensive-stage small-cell lung cancer (ES-SCLC). Upon completion of this activity, participants should be better able to: Review the clinical impact of immunotherapy-based regimens for the management of small-cell lung ...

Jul 28, 2025•28 min

Barbara Burtness, MD - The Pan-Tumor Perspective: Looking Toward the Future of Care With HER3-Directed ADCs for Pretreated Patients With Advanced Solid Tumors

Please visit answersincme.com/DDP860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in oncology discusses human epidermal growth factor receptor 3 (HER3)–directed antibody–drug conjugates (ADCs) for the treatment of patients with advanced solid tumors. Upon completion of this activity, participants should be better able to: Explain the rationale for the pan-tumor use of HER3-directed treatment for patients with loc...

Jul 01, 2025•12 min

Mark A. Socinski, MD - Global Perspectives on Biomarker Testing in NSCLC: Clinical Insights on Optimizing Implementation in Practice

Please visit answersincme.com/ZDE860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in lung cancer discusses best practices for implementing biomarker testing in non-small cell lung cancer (NSCLC) management. Upon completion of this activity, participants should be better able to: Apply current guideline recommendations for biomarker testing to the management of patients with NSCLC, Outline practical strategies wit...

Jun 24, 2025•13 min

David E. Griffith, MD - Guiding Principles in the Management of Refractory Mycobacterium Avium Complex (MAC) Pulmonary Disease: Casing the Evidence to Inform Practical Care

Please visit answersincme.com/FXP860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in pulmonary infectious disease discusses management of refractory Mycobacterium avium complex (MAC) pulmonary disease. Upon completion of this activity, participants should be better able to: Identify patients with refractory Mycobacterium avium complex (MAC) pulmonary disease in a timely manner; Review guideline-recommended therap...

Apr 07, 2025•19 min

Jai Radhakrishnan, MD, MS - IgA Nephropathy in Focus: Novel Treatment Strategies for Nephrologists and PCPs

Please visit answersincme.com/NRR860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in the treatment of IgA nephropathy (IgAN) discusses novel therapeutic approaches in the management of IgAN. Upon completion of this activity, participants should be better able to: Outline the unmet needs in patients with IgAN; Discuss the clinical implications of new and emerging targeted therapies in IgAN; and Identify patient-ce...

Jan 03, 2025•15 min

Pasi A. Jänne, MD, PhD - Expanding Pathways of Care for HER2-Positive Metastatic NSCLC: Beyond Mutation to Overexpression

Please visit answersincme.com/GRK860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in medical oncology discusses the role of antibody–drug conjugates (ADCs) in the treatment of HER2-positive metastatic non–small-cell lung cancer (NSCLC). Upon completion of this activity, participants should be better able to: Recognize the difference between HER2 overexpression and HER2 mutation when managing patients with advance...

Jan 02, 2025•14 min

Arzu Yorgancioglu, MD - A Global Approach to Asthma Management: Examining Biologics

Please visit answersincme.com/TSJ860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in pulmonology discusses systemic therapy, including biologics, for the management of moderate to severe asthma. Upon completion of this activity, participants should be better able to: Review recommended management strategies for moderate to severe asthma; Explain the rationale for the use of biologics in the treatment of patients ...

Jan 02, 2025•22 min

David Harpole, MD / Alfredo Addeo, MD - The Possibilities of Perioperative: Assessing the Use of Perioperative Immunotherapy for Resectable NSCLC

Please visit answersincme.com/860/94256783-replay1 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, experts in non–small-cell lung cancer (NSCLC) discuss the rationale and strategies for integrating perioperative immunotherapeutic approaches to resectable NSCLC care plans, and a patient joins the conversation to share her story. Upon completion of this activity, participants should be better able to: Explain the rationale for ...

Dec 12, 2024•31 sec

Stella Lee, MD - Biologic Therapies for Chronic Rhinosinusitis With Nasal Polyps: Practical, Patient-Centered Perspectives for Providers

Please visit answersincme.com/YWD860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in rhinology discusses the use of biologics for the management of chronic rhinosinusitis with nasal polyps (CRSwNP). Upon completion of this activity, participants should be better able to: Identify key considerations for initiating a biologic therapy in patients with CRSwNP; Discuss the clinical impact of the latest data for novel ...

Dec 12, 2024•19 min

For the best experience, listen in Metacast app for iOS or Android